Evidence map›Paper›PMID 40656248›Full record

ArticleCureus2025

Antibiotic Susceptibility Report of Bacteria Isolated From Blood Cultures of Neutropenic Sepsis Patients Undergoing Chemotherapy.

Tajudeen Musbau, Pyae Phyo Thinn, Aye Moh Moh Paing, Thet Htar Swe, Namitha Sebastian, Eiei Phyo, Bahaa Al-Bubseeree, David Griffith

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tajudeen MusbauHematology, Victoria Hospital, Kirkcaldy, Kirkcaldy, GBR.
Pyae Phyo ThinnMedicine, Victoria Hospital, Kirkcaldy, Kirkcaldy, GBR.
Aye Moh Moh PaingMedicine, Victoria Hospital, Kirkcaldy, Kirkcaldy, GBR.
Thet Htar SweMedicine, Victoria Hospital, Kirkcaldy, Kirkcaldy, GBR.
Namitha SebastianMedicine, Victoria Hospital, Kirkcaldy, Kirkcaldy, GBR.
Eiei PhyoInternal Medicine, NHS Fife, Scotland, GBR.
Bahaa Al-BubseereeHematology, Victoria Hospital, Kirkcaldy, Kirkcaldy, GBR.
David GriffithMicrobiology, Victoria Hospital, Kirkcaldy, Kirkcaldy, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Febrile neutropenia often occurs as a serious complication in patients receiving chemotherapy. It is regarded as an oncologic emergency due to its high morbidity and mortality, necessitating the prompt initiation of empirical antibiotic therapy. While gram-negative bacteria have historically been the primary cause of bloodstream infections in febrile neutropenic patients, recent shifts in bacterial epidemiology and antimicrobial resistance patterns underscore the need for regular evaluation of local data to inform treatment strategies. Methods This retrospective cohort study was conducted in the Department of Hematology at Victoria Hospital, Kirkcaldy, from January to December 2024. It analyzed blood culture results, antibiotic use, chemotherapy regimens, patient characteristics, and microbial susceptibility patterns. A total of 63 patients with an absolute neutrophil count of less than 0.5 were selected through a simple convenience sampling method. Demographic data were collected from ward admission records using a standardized data collection sheet. Blood culture results were retrieved from the laboratory information management system and analyzed using IBM SPSS Statistics for Windows, Version 23.0 (Released 2015; IBM Corp., Armonk, NY, USA). Results Among the 63 patients, 20 (32%) had at least one positive blood culture, with a male-to-female ratio of 3:2. Gram-positive bacteria accounted for the majority of isolates (11; 55%), followed by gram-negative bacteria (eight; 40%), and mixed growth in one case (5%).

Indexed as

acute myeloid leukemia (aml)antibioticsbacteriacvce. coligram negativegram positiveneutropenic sepsissensitivity

Identifiers

PMID40656248
PMCPMC12255959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.